New Zealand's Precision Medicine Innovation is Revolutionizing Global Cancer Treatment

We would formally like to invite you to join us for a networking evening on 28 February, 2024 “New Zealand's Precision Medicine Innovation is Revolutionizing Global Cancer Treatment”.

Bridgewest has partnered with BioTechNZ to bring you a thought-provoking evening to hear about New Zealand’s research and commercial activities in cancer therapeutics that have global impact.   

Come and listen to Dr Robert Weinkove, Clinical Director of the Malaghan Institution and BioOra, talking about the cutting-edge research in cancer treatment, the potential benefits it has for the country and the challenges of getting access here.  

Joining Robert will be Michele Leggott MNZM, New Zealand poet, and an emeritus professor of English at the University of Auckland, who is a patient on the CAR T-cell ENABLE trial, and advocate for CAR-T cell therapy.

Event Details: 

• Date: 28 February 2024
• Location: Bridgewest Auckland, Level 12, 2 Commerce Street, Auckland
• Time: 4:30-6:30 (4:30pm Registration; 5:00 – 5:40pm Presentation and Questions)

Supported by: